ARHGDIA and cancer: These included “RhoGDI signaling” (p‐value = 6.52e−04, z‐score = 3.21), “endocannabinoid cancer inhibition pathway” (p‐value = 6.79e−03, z‐score = 3.21), “PTEN signaling” (p‐value = 1.81e−02, z‐score = 1.74), “chaperone mediated autophagy signalling pathway” (p‐value = 0.04, z‐score = 2.83), and “CDX gastrointestinal cancer signalling pathway” (p‐value = 8.69e−05, z‐score 2.29).